Zohydro
Product Images NDC 43376-215

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zohydro (NDC 43376-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zogenix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Hydrocodone Bitartrate. (Zohydro Extended Release Capsules 1)

The Structural Formula For Hydrocodone Bitartrate. (Zohydro Extended Release Capsules 1)
Chemical structure of the active ingredient of Zohydro by Zogenix, Inc. The image includes molecular formulas and a hydrate notation, with a molecular weight of 494.50.*
FDA Label Image

Percentage Improvement In Average Pain Intensity From Screening To Final Visit (Zohydro Extended Release Capsules 2)

Percentage Improvement In Average Pain Intensity From Screening To Final Visit (Zohydro Extended Release Capsules 2)
A line graph titled 'Percentage Improvement in Average Pain Intensity From Screening to Final Visit' comparing ZOHYDRO ER and placebo. The x-axis shows percent improvement in pain, ranging from ≥10 to ≥100, and the y-axis shows the percentage of subjects improved from 0 to 100. Two lines represent ZOHYDRO ER with higher percentages of subjects improved across all levels of pain improvement compared to placebo, which has consistently lower percentages.*
FDA Label Image

Ndc 43376-210-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 10 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 3)

Ndc 43376-210-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 10 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 3)
Zohydro ER (hydrocodone bitartrate) extended-release capsules 10 mg label. The label includes dosage instructions, storage conditions, and a note to swallow capsules whole without chewing, crushing, or dissolving. The package contains 100 capsules and is labeled for prescription use only. Manufactured by Alkermes Gainesville LLC for Zogenix, Inc.*
FDA Label Image

Ndc 43376-215-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 15 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 4)

Ndc 43376-215-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 15 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 4)
Zohydro ER 15 mg extended-release capsules label showing hydrocodone bitartrate as the active ingredient. The label includes dosing instructions, storage information, quantity of 100 capsules, and manufacturer details from Zogenix, Inc. It notes the capsules must be swallowed whole and are prescription only.*
FDA Label Image

Ndc 43376-220-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 20 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 5)

Ndc 43376-220-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 20 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 5)
Label for Zohydro ER (hydrocodone bitartrate) extended-release capsules, 20 mg strength. The label indicates 100 capsules in the package, with instructions to swallow capsules whole and not to chew, crush, or dissolve. It includes dosage storage information, manufacturer details (Alkermes Gainesville LLC for Zogenix, Inc.), NDC 43376-220-10, and a barcode.*
FDA Label Image

Ndc 43376-230-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 30 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 6)

Ndc 43376-230-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 30 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 6)
Label for Zohydro ER extended-release capsules containing hydrocodone bitartrate, 30 mg strength. The label includes dosage instructions, storage conditions, and a warning to swallow capsules whole. The package contains 100 capsules and is labeled for prescription use only by Zogenix, Inc. Manufactured by Alkermes, Inc.*
FDA Label Image

Ndc 43376-240-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 40 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 7)

Ndc 43376-240-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 40 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 7)
Zohydro ER 40 mg extended-release capsules label showing hydrocodone bitartrate as the active ingredient. The label includes dosage instructions to swallow capsules whole without chewing, crushing, or dissolving. It specifies the package contains 100 capsules for prescription use only and is manufactured by Alkermes Gainesville LLC for Zogenix, Inc.*
FDA Label Image

Ndc 43376-250-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 50 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 8)

Ndc 43376-250-10 Cii Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 50 mg 100 Capsules Rx Only (Zohydro Extended Release Capsules 8)
Label for Zohydro ER 50 mg extended-release capsules containing hydrocodone bitartrate. The label shows instructions to swallow capsules whole and cautions against chewing, crushing, or dissolving. It indicates a package count of 100 capsules and states the product is Rx only. Manufacturer listed as Zogenix, Inc., San Diego, CA, with storage information and NDC 43376-250-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.